Health Technology Assessment (HTA) and regulatory engagement remain central to the SYNTHIA project, helping to ensure that advances in synthetic data are aligned with the practical needs, expectations, and decision-making processes of healthcare regulators and HTA bodies.
On 18 June 2026, the SYNTHIA consortium is holding its third online HTA and Regulatory Advisory Group Meeting, bringing together consortium experts and invited advisory members for an interactive forum focused on the use of synthetic data in realistic HTA and regulatory scenarios.
The meeting will feature a simulated committee discussion involving guest experts with real-world decision-making experience. Through a series of practical vignettes based on situations encountered in HTA and regulatory assessments, participants will explore how synthetic data could realistically help address evidence gaps in healthcare evaluation and decision-making.
The discussion will examine how the suitability, relevance, and methodological challenges of synthetic data may vary depending on the context of use. The expert panel will include clinical experts, patient experts, statisticians, and health economists, who will work through the scenarios together and discuss the appropriateness, potential risks, and methodological considerations linked to synthetic data use in decision-making processes.
Through these discussions, SYNTHIA continues to strengthen the scientific, methodological, and regulatory foundations needed to support responsible and trustworthy use of synthetic data in healthcare innovation.
This meeting is by invitation only.
The first HTA and Regulatory Advisory Group Meeting took place on 2 April 2025, followed by the second meeting on 24 November 2025, continuing SYNTHIA’s ongoing dialogue with HTA and regulatory stakeholders.
